11/18/2026 | Press release | Distributed by Public on 11/18/2026 13:39
TidalHealth has named Robert T. Chasse, MD, the first medical director of research for its Richard A. Henson Research Institute. In this new role, Dr. Chasse will help expand clinical research opportunities, strengthen physician involvement and advance research that could lead to new treatments and improved patient care.
Clinical research plays an important role in advancing healthcare by evaluating new treatments, exploring approaches to disease prevention and management, and identifying opportunities to improve patient outcomes.
As medical director of research, Dr. Chasse will collaborate with physicians, clinical departments and the Research Institute team to grow TidalHealth's clinical research programs. His responsibilities will include identifying new research opportunities, supporting physician-led studies, developing partnerships with research organizations and helping translate research findings into clinical practice.
Dr. Chasse brings more than 25 years of experience at TidalHealth, where he has served as medical director of the intensive care unit since 2000 and medical director of critical care since 2004. Throughout his tenure, he has helped advance pulmonary and critical care services while remaining actively involved in clinical research, medical education and professional leadership.
He has also served as medical director of respiratory therapy at Salisbury University since 1994 and as a clinical associate professor at the Philadelphia College of Osteopathic Medicine since 2020. Dr. Chasse currently serves on the board of directors of the National Board for Respiratory Care and previously served on the board of the American Lung Association of Maryland. He is also a fellow of the American College of Chest Physicians.
As part of this initiative, the Richard A. Henson Research Institute will transition from Population Health to Physician Staff Services. This organizational change is designed to strengthen collaboration between physicians and researchers, support the growth of clinical research programs and create additional opportunities for patients throughout the region to benefit from medical advances.
"Clinical research is an essential component of advancing healthcare," said Robert L. Joyner Jr., PhD, RRT, RRT-ACCS, FAARC, director of the TidalHealth Richard A. Henson Research Institute. "Dr. Chasse brings an exceptional combination of clinical experience, research involvement and physician leadership to this role."
The appointment reflects TidalHealth's continued commitment to advancing clinical research and medical innovation while expanding opportunities for patients across Delmarva to participate in studies that could shape the future of healthcare.
The TidalHealth Richard A. Henson Research Institute supports clinical research across the health system. Through collaboration with physicians, healthcare professionals, academic institutions and research organizations, the Institute works to advance scientific discovery, expand research opportunities and translate findings into improvements in patient care. Its work supports TidalHealth's commitment to delivering innovative, compassionate healthcare through science, technology and education.
Share